These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6409361)

  • 21. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.
    Mukherjee A; Murray RD; Columb B; Gleeson HK; Shalet SM
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):743-8. PubMed ID: 14974916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y modulates growth hormone but not luteinizing hormone secretion from prepuberal gilt anterior pituitary cells in culture.
    Barb CR; Barrett JB
    Domest Anim Endocrinol; 2005 Oct; 29(3):548-55. PubMed ID: 16153503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic and thyroidal regulation of growth hormone in tilapia.
    Melamed P; Eliahu N; Levavi-Sivan B; Ofir M; Farchi-Pisanty O; Rentier-Delrue F; Smal J; Yaron Z; Naor Z
    Gen Comp Endocrinol; 1995 Jan; 97(1):13-30. PubMed ID: 7713377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Somatocrinin (GRF) stimulates the liberation of biologically active somatotropin (GH) in adult man].
    Sassolas G; Boissel JP; Cohen R; Chatelain P; Laporte S; Galleyrand J; Cohen H; Ferry S; Maire P
    C R Seances Acad Sci III; 1983; 296(23):1113-6. PubMed ID: 6416624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human growth hormone-releasing hormone (hGH-RH; hGRF) treatment of four patients with GH deficiency.
    Takano K; Hizuka N; Asakawa K; Chihara K; Sanayama K; Shizume K
    Endocrinol Jpn; 1988 Oct; 35(5):775-81. PubMed ID: 3146502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the growth hormone-releasing hormone test regardless of which fragment is used (GHRH 1-44, 1-40 or 1-29).
    Laron Z
    Isr J Med Sci; 1991 Jun; 27(6):343-5. PubMed ID: 2061025
    [No Abstract]   [Full Text] [Related]  

  • 27. [Correlation between growth velocity and hematologic levels of somatomedin C during the treatment with growth hormones (GH) in subjects with "classic" and "non-classic" deficits of GH].
    Saggese G; Cesaretti G; Cioni C; Bracaloni C; Giannessi N; Cinquanta L
    Minerva Pediatr; 1993; 45(1-2):7-13. PubMed ID: 8316167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatocrinin receptor coupled with cAMP-dependent protein kinase on anterior pituitary granules.
    Lewin MJ; Reyl-Desmars F; Ling N
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6538-41. PubMed ID: 6314330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status of somatocrinin, or GRF, a hypothalamic growth hormone-secreting factor].
    Sassolas G; Guillemin R
    Ann Endocrinol (Paris); 1986; 47(5):332-41. PubMed ID: 3103519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone therapy of short stature.
    Knudtzon J
    Acta Paediatr Scand; 1986 May; 75(3):353-61. PubMed ID: 3088905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatocrinin--growth hormone releasing factor--another hypothalamic hormone for clinical use.
    Romer TE; Rymkiewicz-Kluczyńska B; Szarras-Czapnik M
    Endokrynol Pol; 1987; 38(1):145-53. PubMed ID: 3123206
    [No Abstract]   [Full Text] [Related]  

  • 32. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats.
    Wehrenberg WB; Ling N; Brazeau P; Esch F; Böhlen P; Baird A; Ying S; Guillemin R
    Biochem Biophys Res Commun; 1982 Nov; 109(2):382-7. PubMed ID: 6817757
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth hormone-releasing factor: a neuroendocrine perspective.
    Frohman LA
    J Lab Clin Med; 1984 Jun; 103(6):819-32. PubMed ID: 6327862
    [No Abstract]   [Full Text] [Related]  

  • 34. [Response of growth hormone to somatocrinin in diabetic adolescents].
    Guerin A; Pfister B; Oliver C; Conte-Devolx B
    Presse Med; 1988 Jan 9-16; 17(1):34. PubMed ID: 2964012
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolated growth hormone deficiency: a study in 14 Thai patients.
    Vannasaeng S; Vichayanrat A; Ploybutr S; Inthuprapa M; Tandhanand S
    J Med Assoc Thai; 1982 Jan; 65(1):5-11. PubMed ID: 6153042
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypothalamic adipsia without demonstrable structural lesion.
    Hayek A; Peake GT
    Pediatrics; 1982 Aug; 70(2):275-8. PubMed ID: 6808452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Who needs growth hormones?].
    Vanderschueren-Lodeweyckx M
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():42-3. PubMed ID: 3413774
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.
    Grossman A; Lytras N; Savage MO; Wass JA; Coy DH; Rees LH; Jones AE; Besser GM
    Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1785-7. PubMed ID: 6234047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic hypopituitarism in a patient with a basal encephalocoele--treatment with luteinizing hormone-releasing hormone.
    Morris DV; Mason WP; Wilson-Holt N; Adams J; Keene M; Tanner J; Jacobs HS
    Postgrad Med J; 1984 Sep; 60(707):597-604. PubMed ID: 6384984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to growth hormone-releasing hormone as evidence of hypothalamic defect in optic nerve hypoplasia.
    Leaf AA; Ross RJ; Jones RB; Besser GM; Savage MO
    Acta Paediatr Scand; 1989 May; 78(3):436-9. PubMed ID: 2545075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.